Filing Flows › Journey Medical (DERM) › Q2 2026 › vs Q1 2026
Journey Medical (DERM) Q2 2026 vs Q1 2026 (quarter over quarter)
Journey Medical's revenue rose $2.5M (+16%) from $16.0M in Q1 2026 to $18.5M in Q2 2026.
Journey Medical, Q2 2026: revenue $18.5M (+23% year over year), operating margin 2.5%, net loss $312K, operating cash flow −$1.7M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $18.5M | $16.0M | $2.5M | +16% |
| Net loss | $312K | $2.2M | −$1.9M | -86% |
| Costs & expenses | $18.8M | $18.2M | $631K | +3% |
| Operating costs | $18.1M | $17.5M | $601K | +3% |
| Interest & other, net | $753K | $738K | $15K | +2% |
| Income tax | $15K | $0 | $15K | — |
| Cost of revenue | $6.1M | $6.2M | −$75K | -1% |
| SG&A | $10.9M | $10.1M | $779K | +8% |
| Other operating costs | $969K | $1.1M | −$157K | -14% |
| Operating cash sources | $3.2M | −$1.9M | $5.1M | — |
| Share-based compensation | $1.4M | $989K | $448K | +45% |
| Cash used in operations | $1.7M | −$2.9M | $4.6M | — |
| Net loss absorbed | $312K | $2.2M | −$1.9M | -86% |
| Working capital & other | $2.9M | −$4.2M | $7.0M | — |
Questions
How much did Journey Medical's revenue grow quarter over quarter in Q2 2026?
Journey Medical's revenue rose $2.5M (+16%) from $16.0M in Q1 2026 to $18.5M in Q2 2026.